| Updates and new options in advanced epithelial ovarian cancer treatment KC Kurnit, GF Fleming, E Lengyel Obstetrics and gynecology 137 (1), 108, 2021 | 279 | 2021 |
| CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence KC Kurnit, GN Kim, BM Fellman, DL Urbauer, GB Mills, W Zhang, ... Modern Pathology 30 (7), 1032-1041, 2017 | 279 | 2017 |
| Nuclear β-catenin localization and mutation of the CTNNB1 gene: a context-dependent association G Kim, KC Kurnit, B Djordjevic, C Singh, MF Munsell, WL Wang, AJ Lazar, ... Modern Pathology 31 (10), 1553-1559, 2018 | 113 | 2018 |
| Precision oncology decision support: current approaches and strategies for the future KC Kurnit, EEI Dumbrava, B Litzenburger, YB Khotskaya, AM Johnson, ... Clinical Cancer Research 24 (12), 2719-2731, 2018 | 73 | 2018 |
| Using PARP inhibitors in the treatment of patients with ovarian cancer KC Kurnit, RL Coleman, SN Westin Current treatment options in oncology 19, 1-14, 2018 | 56 | 2018 |
| Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes S Crumley, K Kurnit, C Hudgens, B Fellman, MT Tetzlaff, R Broaddus Modern Pathology 32 (3), 396-404, 2019 | 54 | 2019 |
| “Personalized cancer therapy”: a publicly available precision oncology resource KC Kurnit, AM Bailey, J Zeng, AM Johnson, MA Shufean, L Brusco, ... Cancer research 77 (21), e123-e126, 2017 | 45 | 2017 |
| Prognostic factors impacting survival in early stage uterine carcinosarcoma KC Kurnit, RA Previs, PT Soliman, SN Westin, AH Klopp, BM Fellman, ... Gynecologic oncology 152 (1), 31-37, 2019 | 41 | 2019 |
| Microsatellite instability in endometrial cancer: New purpose for an old test KC Kurnit, SN Westin, RL Coleman Cancer 125 (13), 2154-2163, 2019 | 36 | 2019 |
| Effects of gastrointestinal-type chemotherapy in women with ovarian mucinous carcinoma KC Kurnit, AK Sinno, BM Fellman, A Varghese, R Stone, AK Sood, ... Obstetrics and gynecology 134 (6), 1253, 2019 | 31 | 2019 |
| Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis SA Ackroyd, ES Huang, KC Kurnit, NK Lee Gynecologic oncology 162 (2), 249-255, 2021 | 29 | 2021 |
| Increased prevalence of comorbid conditions in women with uterine cancer KC Kurnit, KK Ward, MT McHale, CC Saenz, SC Plaxe Gynecologic Oncology 138 (3), 731-734, 2015 | 28 | 2015 |
| Loss of CD73 shifts transforming growth factor-β1 (TGF-β1) from tumor suppressor to promoter in endometrial cancer KC Kurnit, A Draisey, RC Kazen, C Chung, LH Phan, JB Harvey, J Feng, ... Cancer letters 505, 75-86, 2021 | 23 | 2021 |
| Primary mucinous ovarian cancer: options for surgery and chemotherapy KC Kurnit, M Frumovitz International Journal of Gynecologic Cancer 32 (11), 2022 | 22 | 2022 |
| Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer K Matsuo, JC Cripe, KC Kurnit, M Kaneda, AS Garneau, GE Glaser, ... Gynecologic oncology 155 (1), 39-50, 2019 | 21 | 2019 |
| Resilience in the face of pandemic: the impact of COVID-19 on the psychologic morbidity and health-related quality of life among women with ovarian cancer M Javellana, FJ Hlubocky, S Somasegar, M Sorkin, KC Kurnit, I Jani, ... JCO Oncology Practice 18 (6), e948-e957, 2022 | 20 | 2022 |
| PARP inhibition in the ovarian cancer patient: Current approvals and future directions KC Kurnit, M Avila, EM Hinchcliff, RL Coleman, SN Westin Pharmacology & therapeutics 213, 107588, 2020 | 15 | 2020 |
| Abstract CT020: Phase I dose escalation of olaparib (PARP inhibitor) and selumetinib (MEK Inhibitor) combination in solid tumors with Ras pathway alterations KC Kurnit, F Meric-Bernstam, K Hess, RL Coleman, P Bhosale, ... Cancer Research 79 (13_Supplement), CT020-CT020, 2019 | 15 | 2019 |
| Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab M Wu, JA Bennett, P Reid, GF Fleming, KC Kurnit Gynecologic Oncology Reports 37, 2021 | 14 | 2021 |
| Differences in sociodemographic disparities between patients undergoing surgery for advanced colorectal or ovarian cancer EM Goldberg, Y Berger, D Sood, KC Kurnit, JS Kim, NK Lee, SD Yamada, ... Annals of surgical oncology 28 (12), 7795-7806, 2021 | 12 | 2021 |
